Lisdexamfetamine Dimesylate API is the dimesylate salt of lisdexamfetamine, a chemically designed prodrug of dextroamphetamine belonging to the central nervous system stimulant class. Lisdexamfetamine consists of dextroamphetamine covalently linked to the naturally occurring amino acid L-lysine. Following administration, enzymatic cleavage releases dextroamphetamine, which produces the principal pharmacological activity.
Lisdexamfetamine Dimesylate is chemically identified as (2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide; methanesulfonic acid, representing lisdexamfetamine associated with two molecules of methanesulfonic acid. The substance has the molecular formula C₁₇H₃₃N₃O₇S₂, molecular weight approximately 455.59 g/mol, and CAS No. 608137-33-3. It contains two defined stereocenters, making stereochemical identity and enantiomeric purity important analytical characteristics.
Lisdexamfetamine is used therapeutically as a CNS stimulant, including in the treatment of attention-deficit/hyperactivity disorder (ADHD) and moderate-to-severe binge-eating disorder in applicable jurisdictions. Its pharmacological activity is primarily attributable to the dextroamphetamine released from the prodrug.
From a pharmaceutical-development perspective, Lisdexamfetamine Dimesylate is relevant to CNS pharmaceutical formulations, stimulant drug development, analytical research, pharmaceutical quality control and formulation development. Because the molecule is a chiral prodrug and contains two mesylate equivalents, appropriate analytical controls for identity, assay, organic impurities, enantiomeric purity and mesylate-related impurities are particularly important.
MEDIOCON INC supplies Lisdexamfetamine Dimesylate for applicable pharmaceutical research, analytical and formulation-development requirements, subject to product availability, applicable regulatory requirements, controlled-substance regulations and supporting documentation. The exact grade, assay, impurity profile, stereochemical purity, water content, packaging and Certificate of Analysis should be confirmed for the specific batch.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white powder |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Lisdexamfetamine Dimesylate API Manufacturer & Supplier in India | MEDIOCON INC (CAS 608137-33-3) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Lisdexamfetamine Dimesylate API Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance